IMMUNIC, INC. — Investor Relations & Filings
Filings indexed
789
across all filing types
Latest filing
2026-05-13
Regulatory Filings
Country
US
United States of America
Listing
US
IMUX
Immunic, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of selective, orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. The company's mission is to create high-quality, oral treatment options that offer comprehensive therapeutic efficacy with favorable safety and tolerability profiles. Its clinical development programs target conditions with significant unmet medical needs, including multiple sclerosis and celiac disease, aiming to provide patients with convenient and effective solutions to manage debilitating symptoms and improve their quality of life.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - IMMUNIC, INC. (0001280776) (Filer) | 2026-05-13 | English | |
| 10-Q - IMMUNIC, INC. (0001280776) (Filer) | 2026-05-13 | English | |
| Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update | 2026-05-13 | English | |
| Immunic to Participate in Investor and Medical Conferences in May | 2026-04-30 | English | |
| 8-K - IMMUNIC, INC. (0001280776) (Filer) | 2026-04-28 | English | |
| Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer | 2026-04-28 | English |
Browse filings by year
22 years- 2026 32 filings
- 2025 75 filings
- 2024 73 filings
- 2023 39 filings
- 2022 66 filings
- 2021 48 filings
- 2020 59 filings
- 2019 78 filings
- 2018 52 filings
- 2017 59 filings
- 2016 46 filings
- 2015 46 filings
- 2014 72 filings
- 2013 22 filings
- 2012 4 filings
- 2011 4 filings
- 2010 5 filings
- 2009 3 filings
- 2007 1 filing
- 2006 1 filing
- 2005 2 filings
- 2004 2 filings
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
SYNTARA LIMITED
Clinical-stage developer of small molecule drugs for inflam…
|
SNT | AU | Professional, scientific and te… |
|
SyntekaBio,Inc.
An AI-driven drug discovery company using supercomputing to…
|
226330 | KR | Professional, scientific and te… |
|
Take Solutions Ltd
Provides specialized domain-led technology and services for…
|
TAKE | IN | Professional, scientific and te… |
|
Tango Therapeutics, Inc.
A clinical-stage biotech developing precision oncology medi…
|
TNGX | US | Professional, scientific and te… |
|
Taysha Gene Therapies, Inc.
Clinical-stage company developing AAV-based gene therapies …
|
TSHA | US | Professional, scientific and te… |
|
Technical Ventures RX Corp.
Develops and commercializes autologous cell therapies for t…
|
— | CA | Professional, scientific and te… |
|
Tectonic Therapeutic, Inc.
Clinical-stage biotech developing biologics targeting G-Pro…
|
TECX | US | Professional, scientific and te… |
|
Telo Genomics Corp.
Quantifies genomic instability via telomere 3D structure to…
|
TELO | CA | Professional, scientific and te… |
|
Telomir Pharmaceuticals, Inc.
Pre-clinical pharma company developing a small molecule for…
|
TELO | US | Professional, scientific and te… |
|
Tempest Therapeutics, Inc.
Clinical-stage oncology company developing small molecule a…
|
TPST | US | Professional, scientific and te… |
IMMUNIC, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/10196/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=10196 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=10196 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=10196 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 10196}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IMMUNIC, INC. (id: 10196)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.